D. E. Shaw & Co., Inc. Dexcom Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $268,800 - $487,452	-4,200 Reduced 17.36%	20,000 $1.34 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $275,775 - $351,125	2,500 Added 11.52%	24,200 $2.74 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $1.42 Million - $1.74 Million	-12,400 Reduced 36.36%	21,700 $3.01 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $1.51 Million - $2.48 Million	20,000 Added 141.84%	34,100 $4.23 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $8.44 Million - $9.82 Million	-75,000 Reduced 84.18%	14,100 $1.81 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $20.4 Million - $24.1 Million	-195,900 Reduced 68.74%	89,100 $10.4 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $2.38 Million - $3.43 Million	-28,000 Reduced 8.95%	285,000 $32.3 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $3.22 Million - $3.97 Million	42,200 Added 15.58%	313,000 $25.2 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $12.8 Million - $25 Million	188,300 Added 228.24%	270,800 $20.2 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $7.46 Million - $10.3 Million	-79,300 Reduced 49.01%	82,500 $42.2 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $428,571 - $537,306	-3,300 Reduced 2.0%	161,800 $86.9 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $5.42 Million - $7.27 Million	50,800 Added 44.44%	165,100 $90.3 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $3.39 Million - $4.52 Million	41,900 Added 57.87%	114,300 $48.8 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $4.27 Million - $5.28 Million	-50,400 Reduced 41.04%	72,400 $26 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $163,800 - $219,450	-2,100 Reduced 1.68%	122,800 $45.4 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $2.7 Million - $3.2 Million	28,300 Added 29.3%	124,900 $51.5 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $2.17 Million - $3.64 Million	34,600 Added 55.81%	96,600 $39.2 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $1.15 Million - $1.82 Million	-24,100 Reduced 27.99%	62,000 $16.7 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $2.24 Million - $3.5 Million	61,100 Added 244.4%	86,100 $18.8 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $134,950 - $186,850	5,000 Added 25.0%	25,000 $3 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $467,000 - $734,400	20,000 New	20,000 $2.86 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account